Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danijela Gnjidic

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
British Journal of Clinical Pharmacology|August 28, 2020
Deprescribing: What do we know, and where to next?Danijela Gnjidic, Emily Reeve
Clinical and Experimental Pharmacology & Physiology|March 27, 2013
Clinical implications from drug-drug and drug-disease interactions in older peopleDanijela Gnjidic, Kristina Johnell
Australian Prescriber|September 16, 2022
The anticholinergic burden: from research to practiceSarah N Hilmer, Danijela Gnjidic
The Medical Journal of Australia|February 5, 2013
Rethinking psychotropics in nursing homesSarah N Hilmer, Danijela Gnjidic
The New England Journal of Medicine|January 11, 2013
Discontinuation of risperidone in Alzheimer's diseaseDanijela Gnjidic, Sarah N Hilmer
Age and Ageing|August 31, 2018
Deprescribing: the emerging evidence for and the practice of the 'geriatrician's salute'Sarah N Hilmer, Danijela Gnjidic
The Medical Journal of Australia|July 25, 2013
Rethinking psychotropics in nursing homes. ReplySarah N Hilmer, Danijela Gnjidic
Australian Prescriber|November 8, 2017
Prescribing for frail older peopleSarah N Hilmer, Danijela Gnjidic
British Journal of Clinical Pharmacology|November 6, 2024
Progress in geriatric pharmacology: Improving drug development, evaluation and use for ageing populationsSarah N Hilmer, Danijela Gnjidic
The New England Journal of Medicine|March 2, 2012
Emergency hospitalizations for adverse drug eventsDanijela Gnjidic, Sarah N Hilmer
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
British Journal of Clinical Pharmacology|August 28, 2020
Deprescribing: What do we know, and where to next?Danijela Gnjidic, Emily Reeve
Clinical and Experimental Pharmacology & Physiology|March 27, 2013
Clinical implications from drug-drug and drug-disease interactions in older peopleDanijela Gnjidic, Kristina Johnell
Australian Prescriber|September 16, 2022
The anticholinergic burden: from research to practiceSarah N Hilmer, Danijela Gnjidic
The Medical Journal of Australia|February 5, 2013
Rethinking psychotropics in nursing homesSarah N Hilmer, Danijela Gnjidic
The New England Journal of Medicine|January 11, 2013
Discontinuation of risperidone in Alzheimer's diseaseDanijela Gnjidic, Sarah N Hilmer
Age and Ageing|August 31, 2018
Deprescribing: the emerging evidence for and the practice of the 'geriatrician's salute'Sarah N Hilmer, Danijela Gnjidic
The Medical Journal of Australia|July 25, 2013
Rethinking psychotropics in nursing homes. ReplySarah N Hilmer, Danijela Gnjidic
Australian Prescriber|November 8, 2017
Prescribing for frail older peopleSarah N Hilmer, Danijela Gnjidic
British Journal of Clinical Pharmacology|November 6, 2024
Progress in geriatric pharmacology: Improving drug development, evaluation and use for ageing populationsSarah N Hilmer, Danijela Gnjidic
The New England Journal of Medicine|March 2, 2012
Emergency hospitalizations for adverse drug eventsDanijela Gnjidic, Sarah N Hilmer
Pageof 21